Atara Biotherapeutics Inc (ATRA)
13.70
-0.68
(-4.73%)
USD |
NASDAQ |
Nov 14, 13:01
Atara Biotherapeutics Profit Margin (Quarterly): -66.51% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -66.51% |
| March 31, 2024 | -116.1% |
| December 31, 2023 | -1.42K% |
| September 30, 2023 | -3.26K% |
| June 30, 2023 | -7.43K% |
| March 31, 2023 | -6.10K% |
| December 31, 2022 | -33.74K% |
| Date | Value |
|---|---|
| September 30, 2022 | -1.89K% |
| June 30, 2022 | 35.80% |
| March 31, 2022 | -1.20K% |
| December 31, 2021 | -1.24K% |
| September 30, 2021 | -1.58K% |
| June 30, 2021 | -2.17K% |
| March 31, 2021 | -2.21K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-33.74K%
Minimum
Dec 2022
35.80%
Maximum
Jun 2022
-4.46K%
Average
-1.73K%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -102.5% |
| Gross Profit Margin (Quarterly) | 83.84% |
| Operating Margin (Quarterly) | -63.66% |
| Return on Net Operating Assets | -211.3% |